Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | ketoconazole | 456201 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | ketoconazole | 456201 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | ketoconazole | 456201 | drug-path |
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | ketoconazole | 456201 | drug-path |
| Notch signaling pathway | R-HSA-157118 | map04330 | ketoconazole | 456201 | drug-path |
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | ketoconazole | 456201 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | ketoconazole | 456201 | drug-path |
| Colorectal cancer | R-HSA-4791275 | map05210 | ketoconazole | 456201 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | mimosine | 13889849 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | mimosine | 13889849 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | mimosine | 13889849 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | mimosine | 13889849 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | mimosine | 13889849 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | mimosine | 13889849 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | mimosine | 13889849 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | mimosine | 13889849 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | mimosine | 13889849 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | mimosine | 13889849 | drug-path |
| B cell receptor signaling pathway | R-HSA-983705 | map04662 | buspirone | 2477 | drug-path |
| T cell receptor signaling pathway | R-HSA-983705 | map04660 | buspirone | 2477 | drug-path |